Ergoteles LLC Atreca, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.59 - $2.74 $10,044 - $17,308	-6,317 Reduced 5.54%	107,783 $169,000
Q2 2022 Aug 12, 2022	BUY	$1.56 - $3.25 $177,996 - $370,825	114,100 New	114,100 $204,000
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $105,565 - $195,005	-21,500 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.82 - $13.8 $168,130 - $296,700	21,500 New	21,500 $183,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.